COVID: New protein-based vaccine up for approval
3 years, 1 month ago

COVID: New protein-based vaccine up for approval

The Hindu  

Sanofi and GlaxoSmithKline are seeking E.U. and U.S. regulatory approval of their protein-based COVID-19 vaccine, which proved 100 per cent effective at preventing severe illness in phase three clinical trials, the duo announced on Wednesday. Official trial results are yet to be published, but the companies reported that in phase three testing, two doses of the vaccine showed 100 per cent protection against severe illness or hospitalization, plus 75 per cent efficacy against moderate illness and 58 per cent efficacy against any symptomatic illness. To compare, mRNA vaccine giants BioNTech-Pfizer and Moderna announced efficacy rates of around 95 per cent protection against severe illness or hospitalization when results from their phase three clinical trials were released in November 2020. According to one study published in the British Medical Journal in January 2021, mRNA vaccine effectiveness against mild to moderate COVID infection significantly decreased from 82 per cent at 3-4 weeks after the second dose of vaccine to 33 per cent at 27-30 weeks after the second dose.

Illness Covid Cent Vaccine Mrna Severe Illness Sanofi Gsk Efficacy Efficacy Rates  proteinbased  vaccines  severe  efficacy  trials  covid  phase  vaccine  illness  mrna  cent  approval

History of this topic

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccin
4 months, 2 weeks ago

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccin

Live Mint  

MUMBAI, India & HYDERABAD, India – Business Wire India PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using machine learning-enabled computational protein design, is pleased to announce that it has been selected for inclusion in the U.S. Government’s Project NextGen. As part of this initiative, the National Institute of Allergy and Infectious Diseases, part of the …

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration
6 months, 3 weeks ago

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration

ABC  

Australia's national drug regulator is evaluating the safety and efficacy of two new COVID-19 vaccines designed to provide better protection against new variants of the virus. While there is no longer much circulation of the original JN.1 variant in Australia, Professor Esterman said the new vaccines — targeting JN.1 — would likely still prove highly effective. While TGA approval isn't …

New push for mRNA bird flu vaccine development: WHO
8 months ago

New push for mRNA bird flu vaccine development: WHO

The Hindu  

The World Health Organisation announced Monday, July 29, 2024, a new project to accelerate the development in poorer countries, of vaccines for human bird flu infections, using cutting-edge messenger RNA technology. Vaccine equity Swiftly developed mRNA Covid vaccines were game-changers during the pandemic, but they also exposed glaring global vaccine inequity and demands for a fairer distribution amid efforts to …

AstraZeneca pulls its COVID-19 vaccine from the European market
10 months, 3 weeks ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

Does frequently updating COVID-19 vaccines have any benefits? | Explained
1 year, 1 month ago

Does frequently updating COVID-19 vaccines have any benefits? | Explained

The Hindu  

Researchers update the composition of influenza vaccines every six months to match the strains of the virus that are circulating in the wild, so that the shots may provide protective immunity against the flu. The VE of COVID-19 vaccines varies according to the disease’s progression as well as the circulating strains. Thus, researchers worldwide rushed to revise COVID-19 vaccines that …

Newest COVID shots are 54% effective in preventing symptoms, CDC finds
1 year, 1 month ago

Newest COVID shots are 54% effective in preventing symptoms, CDC finds

Associated Press  

NEW YORK — The latest versions of COVID-19 vaccines were 54% effective at preventing symptomatic infection in adults, according to the first U.S. study to assess how well the shots work. The 54% finding is similar to what’s been reported in other countries, and it’s also about what was reported for an earlier vaccine version, said the Ruth Link-Gelles of …

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise
1 year, 3 months ago

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise

Daily Mail  

New COVID-19 vaccines targeting the current Omicron variant of the virus are available in community pharmacies throughout Australia. Pharmacy Guild of Australia National President Trent Twomey says the new vaccine available on Monday is targeted at the strain of the virus which is currently circulating among the population. 'With COVID-19 cases on the rise, it is important anyone who is …

Moderna's combined flu and Covid vaccine could cut down visits to your doctor as it proves to be just as effective as separate shots
1 year, 5 months ago

Moderna's combined flu and Covid vaccine could cut down visits to your doctor as it proves to be just as effective as separate shots

Daily Mail  

An experimental combination vaccine for the flu and Covid could be just as effective as getting two separate shots, clinical trials found. An experimental combined vaccine from Moderna for the flu and Covid could be just as effective as getting two separate shots, clinical trials found Less than one-fifth of US adults plan to get the updated Covid booster, and …

Novavax’s COVID-19 vaccine gets the green light from the FDA, giving third option for protection
1 year, 5 months ago

Novavax’s COVID-19 vaccine gets the green light from the FDA, giving third option for protection

Salon  

On Tuesday, the Food and Drug Administration authorized the use of a new Novavax vaccine specifically targeted to protect against the latest Omicron circulating strains. Following a bumpy rollout of the Moderna and Pfizer vaccines, it will bring another option to the table for those who are ready to roll up their sleeves and get vaccinated amid a rise in …

Years of research laid the groundwork for speedy COVID-19 shots
1 year, 5 months ago

Years of research laid the groundwork for speedy COVID-19 shots

Associated Press  

The Nobel Prize in Medicine was awarded Monday to two scientists whose work led to the mRNA vaccines against COVID-19. “Abject giddiness,” is how Dr. C. Buddy Creech, a Vanderbilt University vaccine expert, described scientists’ reactions when separate studies showed the two candidates were about 95% effective. Billions in company and government funding certainly sped up vaccine development — and …

Scientists whose work on mRNA paved the way for first COVID-19 vaccines win Nobel Prize
1 year, 5 months ago

Scientists whose work on mRNA paved the way for first COVID-19 vaccines win Nobel Prize

LA Times  

Dr. Drew Weissman, left, a physician-scientist, and biochemist Katalin Karikó won the Nobel Prize in medicine for discoveries that enabled the creation of mRNA vaccines against COVID-19 and that could be used to develop other shots in the future. “This year’s Nobel Prize recognizes their basic science discovery that fundamentally changed our understanding of how mRNA interacts with the immune …

The next pandemic is already coming and it could kill millions more than Covid. We need to prepare for it now... writes experts KATE BINGHAM and TIM HAMES
1 year, 6 months ago

The next pandemic is already coming and it could kill millions more than Covid. We need to prepare for it now... writes experts KATE BINGHAM and TIM HAMES

Daily Mail  

The next major pandemic is coming. It’s already on the horizon, and could be far worse — killing millions more people — than the last one. To combat Disease X — as the World Health Organisation ominously calls it — we will once again need vaccines to be engineered and delivered in record time. It’s already on the horizon, and …

Updated COVID vaccines will be available later this week, recommended for everyone six months and up
1 year, 6 months ago

Updated COVID vaccines will be available later this week, recommended for everyone six months and up

Salon  

A new, fourth round of COVID-19 booster shots was approved Tuesday, following the recommendation of federal health agencies, which will make the vaccines available to Americans later this week. The Centers for Disease Control and Prevention followed suit this afternoon, with CDC director Mandy Cohen recommending updated vaccination for "everyone 6 months and older to better protect you and your …

Should you get the new COVID booster? The CDC is about to decide
1 year, 6 months ago

Should you get the new COVID booster? The CDC is about to decide

LA Times  

A nurse prepares a syringe of a COVID-19 vaccine. The CDC’s vaccine advisors will soon decide whether to recommend the latest COVID-19 boosters only for frail, older, sick and immunocompromised people or to offer it to everyone over 6 months of age. “I don’t plan to get it myself,” said Dr. Paul Offit, the director of the Vaccine Education Center …

World Health Organization calls for NEW Covid booster shots
1 year, 10 months ago

World Health Organization calls for NEW Covid booster shots

Daily Mail  

The World Health Organization has called for new Covid shots to be developed for this winter that targets mutated variants. The World Health Organization has recommended new Covid shots are developed this winter to target mutated variants The recommendation was made by the WHO's Technical Advisory Group on Covid Vaccine Composition. The above graph shows the number of Americans who …

China approves its first mRNA vaccine for Covid-19
2 years ago

China approves its first mRNA vaccine for Covid-19

Hindustan Times  

China has approved its first locally developed messenger RNA vaccine against Covid-19, its manufacturer said Wednesday, months after the relaxation of strict Covid-zero regulations sparked a surge in cases. China Covid: mRNA vaccines are considered among the most effective in reducing severe infections and deaths. mRNA vaccines are considered among the most effective in reducing severe infections and deaths. While …

mRNA Covid-19 vaccines can increase serious adverse events? US researcher claims
2 years, 2 months ago

mRNA Covid-19 vaccines can increase serious adverse events? US researcher claims

India TV News  

A US-based researcher has claimed that the messenger RNA Covid-19 vaccine can increase serious adverse events in people, including sudden cardiac deaths. Joseph Fraiman, the lead author of the peer-reviewed research that re-analysed Pfizer & Moderna trials for mRNA Covid-19 vaccine, has tweeted: "I believe the mRNA Covid-19 vaccines need to be withdrawn". In another tweet, he mentioned that the …

As COVID-19 spikes in California, booster shots could make all the difference
2 years, 3 months ago

As COVID-19 spikes in California, booster shots could make all the difference

LA Times  

With coronavirus cases and hospitalizations rising in Los Angeles County, officials are voicing new confidence in the effectiveness of the updated COVID-19 booster shot. New data has found that the updated COVID-19 vaccines offer “significant additional protection” against symptomatic infection in people who were previously vaccinated or boosted with the older formula. “We have seen very low uptake of the …

Researchers Prepare New mRNA Flu Shot that Can Target All Strains, Prevent Influenza Pandemic
2 years, 4 months ago

Researchers Prepare New mRNA Flu Shot that Can Target All Strains, Prevent Influenza Pandemic

News 18  

Researchers from the University of Pennsylvania are developing a new mRNA vaccine targeting all known flu strains in a single shot and said the vaccine is showing promise in animal studies. Scott Hensley, an immunologist at the University of Pennsylvania in Philadelphia told CBC: “Our approach was to make a vaccine that encoded every influenza subtype and lineage that we …

US renews push for COVID boosters as data show they protect
2 years, 4 months ago

US renews push for COVID boosters as data show they protect

Associated Press  

Americans who got the updated COVID-19 booster shots are better protected against symptomatic infection than those who haven’t — at least for now, U.S. health officials said Tuesday. Speaking at a White House briefing expected to be his last before he retires from the government at the end of year, Fauci said what “may be the final message I give …

RNA vaccines rose to prominence during COVID, but we've only scratched the surface of their potential
2 years, 4 months ago

RNA vaccines rose to prominence during COVID, but we've only scratched the surface of their potential

ABC  

In high school biology, students are taught the central concept of genetics in a very simple way: DNA makes RNA, RNA makes protein, and protein makes life. There's more inside the RNA universe Vaccines that contain messenger RNA, or mRNA, have been studied for decades, but the release of them during the COVID-19 pandemic was the first of its kind. …

Covid remains deadly for half a million Britons, and the government isn’t talking about it
2 years, 4 months ago

Covid remains deadly for half a million Britons, and the government isn’t talking about it

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

U.S. clears Novavax vaccine for use as COVID-19 booster
2 years, 5 months ago

U.S. clears Novavax vaccine for use as COVID-19 booster

LA Times  

A vial of the COVID-19 vaccine made by Novavax. U.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Novavax. The Food and Drug Administration said the new booster option is for people 18 and older who can’t get the Omicron-targeting boosters from Pfizer-BioNTech or Moderna for medical or accessibility reasons — or who otherwise would …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 6 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

Tweaked COVID boosters close but how much will they help?
2 years, 7 months ago

Tweaked COVID boosters close but how much will they help?

Associated Press  

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but still up in the air is how much benefit the booster shots will offer, who should get one -- and how soon. Dr. Peter Marks, the FDA’s vaccine chief, said Thursday that once authorized, the tweaked boosters could help right away …

In race for monkeypox vaccines, experts see repeat of COVID-19
2 years, 7 months ago

In race for monkeypox vaccines, experts see repeat of COVID-19

The Hindu  

Moves by rich countries to buy large quantities of monkeypox vaccine, while declining to share doses with Africa, could leave millions of people unprotected against a more dangerous version of the disease and risk continued spillovers of the virus into humans, public health officials are warning. Yet while monkeypox is much harder to spread than COVID-19, experts warn that if …

CDC endorses more traditional Novavax COVID shot for adults
2 years, 8 months ago

CDC endorses more traditional Novavax COVID shot for adults

Associated Press  

U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax -- a more traditional kind of vaccine, health officials said Tuesday. THE NOVAVAX DIFFERENCE All of the vaccines used in the U.S. train the body to fight the coronavirus by recognizing its outer coating, the spike protein -- and the first three options essentially …

The CDC endorses Novavax, a more traditional COVID vaccine, for adults
2 years, 8 months ago

The CDC endorses Novavax, a more traditional COVID vaccine, for adults

NPR  

The CDC endorses Novavax, a more traditional COVID vaccine, for adults Enlarge this image toggle caption Georg Wendt/AP Georg Wendt/AP U.S. adults who haven't gotten any COVID-19 shots yet should consider a new option from Novavax — a more traditional kind of vaccine, health officials said Tuesday. The Novavax difference All of the vaccines used in the U.S. train the …

CDC endorses more traditional Novavax COVID-19 shot
2 years, 8 months ago

CDC endorses more traditional Novavax COVID-19 shot

LA Times  

A dish with syringes containing the Novavax COVID-19 vaccine sits in a refrigerator ready for use. U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax — a more traditional kind of vaccine, health officials said Tuesday. The Novavax difference All of the vaccines used in the U.S. train the body to fight the …

US regulators OK new COVID-19 shot option from Novavax
2 years, 8 months ago

US regulators OK new COVID-19 shot option from Novavax

Associated Press  

The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. -- and one that’s already available in Europe and multiple other countries. Novavax also has submitted data on booster …

FDA OKs new COVID-19 shot from Novavax
2 years, 8 months ago

FDA OKs new COVID-19 shot from Novavax

LA Times  

Vials of Novavax’s COVID-19 vaccines wait to be labeled at a manufacturing facility in India. Novavax makes a more traditional type of protein vaccine that’s unlike the three other COVID-19 shots available for use in the U.S. Novavax Chief Executive Stanley Erck said he expected the U.S. to expand use of the vaccine beyond unvaccinated adults fairly quickly. Novavax also …

Will Americans have the right COVID-19 vaccine this fall? Maybe
2 years, 8 months ago

Will Americans have the right COVID-19 vaccine this fall? Maybe

LA Times  

A man walks underneath the marquee of the Alex Theatre in Glendale. Determining which recipe should go into those doses to induce optimal protection — the vaccine’s “composition” — is an exercise in educated guesswork. Getting a timely and accurate fix on all this “is truly a challenge, and it is science at its hardest,” Dr. Peter Marks, the U.S. …

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots
2 years, 8 months ago

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots

News 18  

The wait for the roll-out of Biological E’s Corbevax vaccine as a heterologous booster shot may continue for a while, News18.com has learnt. Corbevax was approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India in the first week of June. Thankfully, Omicron does not cause severe disease and hence there is …

Covid vaccine effectiveness falls to 0% a year after first series
2 years, 8 months ago

Covid vaccine effectiveness falls to 0% a year after first series

NL Times  

People who have only received the first and second vaccine shots against Covid-19 are barely protected against a coronavirus infection one year after the injections. By that time, vaccine effectiveness falls to 0 percent, according to the RIVM, the Dutch public health institute. Those who received a booster shot in the interim still receive protection against serious symptoms of the …

FDA advisers recommend updating COVID booster shots for fall
2 years, 9 months ago

FDA advisers recommend updating COVID booster shots for fall

Associated Press  

At least some U.S. adults may get updated COVID-19 shots this fall, as government advisers voted Tuesday that it’s time to tweak booster doses to better match the most recent virus variants. Their combination shots, what scientists call “bivalent” vaccines, substantially boosted levels of antibodies capable of fighting that variant, more than simply giving another dose of today’s vaccine. Marks …

FDA grapples with whether to modify COVID vaccine for fall
2 years, 9 months ago

FDA grapples with whether to modify COVID vaccine for fall

LA Times  

The Food and Drug Administration will debate Tuesday whether it’s time to update COVID vaccine formulas. “This is science at its toughest,” said FDA vaccine chief Dr. Peter Marks, adding that a final decision is expected within days of the advisory panel’s recommendation. In an analysis prepared for Tuesday’s meeting, FDA officials acknowledged targeting last winter’s version of Omicron is …

FDA advisers to weigh expanding Covid-19 vaccines to younger kids
2 years, 9 months ago

FDA advisers to weigh expanding Covid-19 vaccines to younger kids

CNN  

CNN — Several months after older children became eligible to get vaccinated against Covid-19, the United States might be just days away from offering vaccines to those younger than 5. Pfizer’s data People 5 and older are already eligible for Pfizer/BioNTech’s two-dose Covid-19 vaccine and a booster dose – but in Wednesday’s meeting, VRBPAC members will discuss whether to add …

The Most Common Questions About The Novavax COVID Vaccine, Answered
2 years, 9 months ago

The Most Common Questions About The Novavax COVID Vaccine, Answered

Huff Post  

LOADING ERROR LOADING As scientists and health experts continue to learn how to fight the virus, more treatment and prevention methods are becoming available ― including additional vaccines. Novavax’s COVID-19 shot “is a technology commonly used in most other vaccines, such as flu, hepatitis B and shingles,” said Dr. Mahdee Sobhanie, an infectious diseases physician at Ohio State University Wexner …

FDA advisers back Novavax COVID-19 shots as fourth US option
2 years, 9 months ago

FDA advisers back Novavax COVID-19 shots as fourth US option

Firstpost  

The FDA advisory panel voted that the benefits of two primary Novavax doses outweigh its risks — but they had a lot of questions about the shots’ role at this point in the pandemic. Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. FDA’s vaccine chief …

FDA advisers back Novavax COVID shots as 4th US option
2 years, 9 months ago

FDA advisers back Novavax COVID shots as 4th US option

Associated Press  

American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. FDA’s vaccine chief Dr. Peter Marks …

FDA advisory panel gives near-unanimous recommendation to Novavax's COVID-19 vaccine
2 years, 9 months ago

FDA advisory panel gives near-unanimous recommendation to Novavax's COVID-19 vaccine

Daily Mail  

Novavax's COVID-19 vaccine received near-unanimous approval for use in adults over 18 years old on Tuesday, paving the way for it to become the fourth jab and first protein-based shot to be rolled out in America. Unlike Pfizer and Moderna's shots, the Novavax jab uses the same protein-based technology as flu vaccines, which expose the immune system to spike proteins …

FDA advisors back Novavax COVID-19 vaccine as a new U.S. option
2 years, 9 months ago

FDA advisors back Novavax COVID-19 vaccine as a new U.S. option

LA Times  

American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisors to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the vaccine made by latecomer Novavax, a protein vaccine that’s made with a more conventional tech- nology than today’s U.S. options. …

Advisers to the FDA back Novavax COVID vaccine
2 years, 9 months ago

Advisers to the FDA back Novavax COVID vaccine

NPR  

Advisers to the FDA back Novavax COVID vaccine Enlarge this image toggle caption Karen Ducey/Getty Images Karen Ducey/Getty Images In a 21-0 vote with one abstention, advisers to the Food and Drug Administration recommended that the agency authorize Novavax's two-dose vaccine against COVID-19. In comments to the committee before its vote, Dr. Peter Marks, the FDA's top vaccine official said, …

Novavax hopes its COVID shot wins over FDA, vaccine holdouts
2 years, 9 months ago

Novavax hopes its COVID shot wins over FDA, vaccine holdouts

Associated Press  

— Americans may soon get a new COVID-19 vaccine option -- shots made with a more tried-and-true technology than today’s versions. “What I’ve seen of the Novavax data so far is it’s a really impressive protein vaccine,” said University of Pennsylvania immunologist E. John Wherry. Novavax, a small biotech company, created the vaccine in its research lab, but the Serum …

Q&A: Novavax hopes its COVID shot wins over FDA, vaccine holdouts
2 years, 9 months ago

Q&A: Novavax hopes its COVID shot wins over FDA, vaccine holdouts

LA Times  

Americans may soon get a new COVID-19 vaccine option — shots made with a more tried-and-true technology than today’s versions. “What I’ve seen of the Novavax data so far is it’s a really impressive protein vaccine,” said University of Pennsylvania immunologist E. John Wherry. Novavax, a small biotech company, created the vaccine in its research lab, but the Serum Institute …

Efficacy, Safety of mRNA Vaccines among Younger Children at Par with Vaccines for Adults: New Study
2 years, 9 months ago

Efficacy, Safety of mRNA Vaccines among Younger Children at Par with Vaccines for Adults: New Study

News 18  

Messenger-RNA vaccines given to young children aged 6 to 11 years are safe, effective and at par with the vaccines given to adults, according to an evaluation published in The New England Journal of Medicine. “Two 50-μg doses of the mRNA-1273 vaccine were found to be safe and effective in inducing immune responses and preventing Covid-19 in children 6 to …

Germany recognises Bharat Biotech's Covaxin for travel from June 1
2 years, 10 months ago

Germany recognises Bharat Biotech's Covaxin for travel from June 1

India TV News  

Highlights WHO in November last year issued an emergency use listing for Covaxin The step added a growing portfolio of vaccines validated for the prevention of COVID-19 WHO's EUL procedure assesses the quality, safety and efficacy of COVID-19 vaccines Germany has recognised the WHO-listed Bharat Biotech's COVID vaccine Covaxin, for travel to the country starting June 1. World Health Organization …

India’s ‘other’ COVID vaccines: Status of under-trial & approved but unused jabs
2 years, 10 months ago

India’s ‘other’ COVID vaccines: Status of under-trial & approved but unused jabs

The Hindu  

As India nears the 200-crore COVID-19 vaccination mark, Serum Institute of India’s Covishield accounts for 80 per cent of the jabs, while Bharat Biotech’s Covaxin accounts for 16.75 per cent jabs. As of date, India has granted emergency usage authorisation to nine COVID-19 vaccine candidates in total – Covishield, Covaxin, Covovax, Corbevax, Zydus Cadila’s ZyCoV-D, Moderna’s Spikevax, Sputnik-V, Sputnik Light, …

With old-school technology, can Novavax win over COVID vaccine skeptics?
2 years, 10 months ago

With old-school technology, can Novavax win over COVID vaccine skeptics?

LA Times  

A vial of the Novavax COVID-19 vaccine is ready for use in a Phase 3 clinical trial in London. Some people “may prefer tried and true technologies” for COVID-19 vaccines, said Dr. Filip Dubovsky, the chief medical officer of Novavax. It’s even possible a single Novavax shot could target multiple coronavirus variants in one shot, although Dubovsky said it makes …

Africa's COVID vaccine production line in jeopardy
2 years, 10 months ago

Africa's COVID vaccine production line in jeopardy

The Hindu  

Trisha shakes her head when asked if she's vaccinated. 'A massive setback for Africa's plans' In the absence of orders or commitments, Aspen is considering the repurposing of two COVID-19 production lines for the manufacture of other products. "The continent would lose its only existing COVID vaccine manufacturing capacity," Nicolaou says. Africa's major public health body, the Africa Centers for …

Discover Related